BioLargo, Inc. Presents Investor Conference Webcast Slides

What Happened

• BioLargo, Inc. announced a Regulation FD disclosure in an 8-K filed September 11, 2026, reporting that it presented a slide deck at a webcast investor conference on September 10, 2026, at 1:00 PM Pacific Time.
• The presentation slides were furnished as Exhibit 99.1 to the filing and are incorporated by reference.

Key Details

• Filing date: September 11, 2026 (Form 8-K).
• Presentation date/time: September 10, 2026, at 1:00 PM Pacific Time.
• Disclosure type: Item 7.01 (Regulation FD disclosure); exhibits listed under Item 9.01 include Exhibit 99.1 (slide deck) and Exhibit 104 (interactive cover page data).
• The filing does not report earnings, executive changes, or other financial statements — it supplies the investor presentation slides.

Why It Matters

• This 8-K publicly distributes the company’s investor presentation under Regulation FD, ensuring the information was shared broadly rather than selectively.
• Investors should review the attached slide deck (Exhibit 99.1) for any business updates or material information presented during the webcast, since the 8-K itself does not summarize slide content or provide financial results.